IRLAB Q4: Upcoming Pirepemat readout in focus - Redeye
Redeye returns following IRLAB's Q4 report and recent news in the company. We note that 2025 will be an important year for the company - with an important readout in Pirepemat already now in Q1.
ANNONS
Redeye returns following IRLAB's Q4 report and recent news in the company. We note that 2025 will be an important year for the company - with an important readout in Pirepemat already now in Q1.